Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
144/A
Filing Date
6/24/2024
Updated
6/25/24, 2:44 PM
Filing
144/A
Earnings Release
Exhibits
144/A
Amended Notice of Proposed Sale of Securities